Page last updated: 2024-08-17

medroxyprogesterone acetate and Pancreatic Neoplasms

medroxyprogesterone acetate has been researched along with Pancreatic Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kuramoto, M; Ogawa, M; Yamashita, J	1
Abe, M; Ogawa, M; Yamashita, J	2
Abe, K	1

Reviews

2 review(s) available for medroxyprogesterone acetate and Pancreatic Neoplasms

Article	Year
Endocrine therapy in pancreatic carcinoma. Oncology, 1998, Volume: 55 Suppl 1 Topics: Antineoplastic Agents, Hormonal; Estrogen Antagonists; Humans; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Tissue Plasminogen Activator	1998
[Hormone therapy of neoplasms]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Mar-10, Volume: 80, Issue:3 Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen	1991

Other Studies

2 other study(ies) available for medroxyprogesterone acetate and Pancreatic Neoplasms

Article	Year
Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells. Cancer, 1995, Mar-15, Volume: 75, Issue:6 Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured	1995
Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation. Cancer, 2000, May-01, Volume: 88, Issue:9 Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Carcinoma; Cell Adhesion; Cell Count; Cell Nucleus; DNA Fragmentation; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Growth Inhibitors; Humans; Immunoblotting; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	2000

Article

Year

Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.

Cancer, 1995, Mar-15, Volume: 75, Issue:6

Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured

1995

Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.

Cancer, 2000, May-01, Volume: 88, Issue:9

Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Carcinoma; Cell Adhesion; Cell Count; Cell Nucleus; DNA Fragmentation; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Growth Inhibitors; Humans; Immunoblotting; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured

2000